TrialNeurology(R) neuroimmunology & neuroinflammation2026

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Sean J Pittock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.